627 related articles for article (PubMed ID: 19641275)
1. Urine toxicology testing in chronic pain management.
Cone EJ; Caplan YH
Postgrad Med; 2009 Jul; 121(4):91-102. PubMed ID: 19641275
[TBL] [Abstract][Full Text] [Related]
2. The role of urine toxicology in chronic opioid analgesic therapy.
Compton P
Pain Manag Nurs; 2007 Dec; 8(4):166-72. PubMed ID: 18036504
[TBL] [Abstract][Full Text] [Related]
3. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.
McCarberg BH
Postgrad Med; 2011 Nov; 123(6):124-31. PubMed ID: 22104461
[TBL] [Abstract][Full Text] [Related]
4. Urine drug testing in chronic pain.
Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
[TBL] [Abstract][Full Text] [Related]
5. Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse.
McCarberg BH
Postgrad Med; 2011 Nov; 123(6):132-9. PubMed ID: 22104462
[TBL] [Abstract][Full Text] [Related]
6. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables.
Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD
Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030
[TBL] [Abstract][Full Text] [Related]
7. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
[TBL] [Abstract][Full Text] [Related]
8. The use of urine drug testing to monitor patients receiving chronic opioid therapy for persistent pain conditions.
Tellioglu T
Med Health R I; 2008 Sep; 91(9):279-80, 282. PubMed ID: 18834046
[TBL] [Abstract][Full Text] [Related]
9. The role of urine drug testing for patients on opioid therapy.
Pergolizzi J; Pappagallo M; Stauffer J; Gharibo C; Fortner N; De Jesus MN; Brennan MJ; Richmond C; Hussey D;
Pain Pract; 2010; 10(6):497-507. PubMed ID: 20412503
[TBL] [Abstract][Full Text] [Related]
10. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.
Fishbain DA; Cole B; Lewis J; Rosomoff HL; Rosomoff RS
Pain Med; 2008; 9(4):444-59. PubMed ID: 18489635
[TBL] [Abstract][Full Text] [Related]
11. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
[TBL] [Abstract][Full Text] [Related]
12. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
[TBL] [Abstract][Full Text] [Related]
13. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
[TBL] [Abstract][Full Text] [Related]
14. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse.
Wiedemer NL; Harden PS; Arndt IO; Gallagher RM
Pain Med; 2007; 8(7):573-84. PubMed ID: 17883742
[TBL] [Abstract][Full Text] [Related]
15. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
Gupta A; Patton C; Diskina D; Cheatle M
Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
[TBL] [Abstract][Full Text] [Related]
16. Opioids for the treatment of chronic noncancer pain.
Warner EA
Am J Med; 2012 Dec; 125(12):1155-61. PubMed ID: 22944349
[TBL] [Abstract][Full Text] [Related]
17. Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings.
Michna E; Jamison RN; Pham LD; Ross EL; Janfaza D; Nedeljkovic SS; Narang S; Palombi D; Wasan AD
Clin J Pain; 2007 Feb; 23(2):173-9. PubMed ID: 17237667
[TBL] [Abstract][Full Text] [Related]
18. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
[TBL] [Abstract][Full Text] [Related]
19. Rational use and interpretation of urine drug testing in chronic opioid therapy.
Reisfield GM; Salazar E; Bertholf RL
Ann Clin Lab Sci; 2007; 37(4):301-14. PubMed ID: 18000286
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
Manchikanti L; Malla Y; Wargo BW; Fellows B
Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
